🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Age-appropriate exercise started immediately after treatment initiation is a promising strategy to reduce anticancer treatment-related side effects. New study protocol for the INTERACT project, published in Eric Zurrin in Pediatrics #Pediatric frontiersin.org/articles/10.33…

Explaining our upcoming RCT investigating the potential of GLP-1 analogue protecting against gut barrier damage following high-dose chemotherapy in this peace of art at #BridgeBootCamp2022 @UCPH_BRIDGE

When children diagnosed with #ependymoma have a causative #germline mutation, they may not have ependymoma at all. But rather a different childhood brain tumor. Funders Børnecancerfonden Kræftens Bekæmpelse Rigshospitalet #cancerpredisposition #genomics #pediatriconcology

Friday morning’s 1-slide-abstract paper. Ulrik Stoltze

Great to hear Marie Neu present the FORTEe 🎗️ for the child cancer lab in Copenhagen Bonkolab!

We’re looking forward to this week’s in-person #SIOP2022 conference. Nine Bonkolab researchers are joining. Talks ranging from cancer etiology to life with and after cancer. SIOPE 🎗️

What an interesting talk by Hanne Bækgaard Larsen on how a cancer diagnosis affect the child's classmates and what we can do about it! Bonkolab #SIOP2022

At #EISG2022 learning a lot from the expert in the field of incretins while trying to disclose the role of GLP-1 in toxicity following high-dose chemotherapy and #HSCT

It was a great honour to present the RESPECT study at #SIOP2022 yesterday!

#SIOP2022 Young Investigator Award. ⁦Martin Kaj Fridh, PhD⁩ ⁦Ulrik Stoltze⁩ #childhoodcancer #exercise #rehabilitation #wilmstumor #cancerpredisposition rigshospitalet.dk/presse-og-nyt/…

Metabolic syndrome is observed at high frequency in survivors of hsct in childhood Check out our paper (Vadmand et al.) on the role of incretin secretion on #lateeffects in paediatric HSCT survivors, just published in #JCEM ⁦Bonkolab⁩ academic.oup.com/jcem/advance-a…

Join the #CLEARconference on early adverse reactions to childhood #leukemia. June 1st, 2nd & 3rd 2023 in Copenhagen. See more and register at clearcopenhagen.dk